Replies to post #163516 on Cytodyn Inc (CYDY)

[DonDonDonDon]

ACTIV-1 IM (Immune Modulators) was launched with much fanfare in Oct 2020. It was to enroll approximately 2000 patients over a 6 month period. ie April 2021. Infliximab / Abatacept / Cenicriviroc were selected as the GAME CHANGERS.

Being run as an ADAPTIVE STUDY, they know EXACTLY how each drug is doing ..and have the power to change Endpoints with impunity. Why have we not heard the BRILLIANT RESULTS SO FAR..??

BECAUSE..

There is only one LERONLIMAB.

You haven't heard anything about the results of the ACTIV-1 trial because it is still in progress. The fact that the government sees the data as it comes in doesn't mean they announce the results as they come in. I'm surprised this needs explaining.

[BBalls-N-CowTown]

Great post!

[Learning53]

Missed seeing you for a while, am very sorry about what's taking place in India. What a different outcome we might be looking at if only our FDA had given leronlimab immediate approval. Instead a terrible tragedy in your homeland. I hope they can turn things around there.

In the meantime - Rockleo, please stay safe.

[Emergcy]

As you know , I reached out to Modi (to his personal email) and his direct offices guys. He got all information what is needed. I believe Indian government doesn't care how many are dying. It is like in all other countries, they care only on their pockets.

[misiu143]

Rockleo , great post ..
And very curious , more studies for dr Fauci approved by FDA as Adaptive Design Studies , when they may “PICK” at the results during active study , and choose endpoints depending what they see .

Remdesivir ,
Lenzilumab and now all those ..

FDA approving all this type of study as we see ONLY for Dr Fauci designed studies and Dr Fauci favorites ..

How no one in NIH , FDA see anything wrong with that .

All imo